Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christian Thomas

Showing results (231-240 of 441) with videos related to

Pageof 45
Sort By:
World Journal of Urology|August 28, 2021
Contemporary treatment trends for upper urinary tract stones in a total population analysis in Germany from 2006 to 2019: will shock wave lithotripsy become extinct?Roman Herout, Martin Baunacke, Christer Groeben, et al.
Molecular Cancer Therapeutics|August 23, 2013
Synergistic targeting of PI3K/AKT pathway and androgen receptor axis significantly delays castration-resistant prostate cancer progression in vivoChristian Thomas, Francois Lamoureux, Claire Crafter, et al.
Urologia Internationalis|January 21, 2024
The Role of Multiparametric MRI (mpMRI) in the Prediction of Adverse Prostate Cancer Pathology in Radical Prostatectomy SpecimenAndreas Riedel, Marlene Michael, Jenny Grünberg, et al.
BJUI Compass|August 20, 2025
A machine learning algorithm for automatic tumour board recommendations in prostate cancer patientsMarcus Sondermann, Hannah Glaser, Anke Rentsch, et al.
World Journal of Urology|February 16, 2024
Old for young kidney transplantation: a responsible option for our patients to reduce waiting time?Philip Zeuschner, Janine Mihm, Urban Sester, et al.
Lancet (London, England)|January 24, 2021
Neuropathology associated with SARS-CoV-2 infectionKristof Egervari, Christian Thomas, Johannes A Lobrinus, et al.
Molecular Cancer Therapeutics|March 16, 2013
A novel antiandrogen, Compound 30, suppresses castration-resistant and MDV3100-resistant prostate cancer growth in vitro and in vivoHidetoshi Kuruma, Hiroaki Matsumoto, Masaki Shiota, et al.
Urologic Oncology|August 5, 2019
Comparative assessment of docetaxel for safety and efficacy between hormone-sensitive and castration-resistant metastatic prostate cancerRene Mager, Olga Savko, Katharina Böhm, et al.
World Journal of Urology|November 1, 2022
Negative multiparametric magnetic resonance imaging for prostate cancer: further outcome and consequencesMaximilian Haack, Vanessa Miksch, Zhe Tian, et al.
Open Forum Infectious Diseases|March 7, 2023
Hearing Loss in Bacterial Meningitis Revisited-Evolution and RecoveryElisa Skovgaard Jensen, Per Cayé-Thomasen, Jacob Bodilsen, et al.
Pageof 45

Showing results (231-240 of 441) with videos related to

Sort By:
Pageof 45
World Journal of Urology|August 28, 2021
Contemporary treatment trends for upper urinary tract stones in a total population analysis in Germany from 2006 to 2019: will shock wave lithotripsy become extinct?Roman Herout, Martin Baunacke, Christer Groeben, et al.
Molecular Cancer Therapeutics|August 23, 2013
Synergistic targeting of PI3K/AKT pathway and androgen receptor axis significantly delays castration-resistant prostate cancer progression in vivoChristian Thomas, Francois Lamoureux, Claire Crafter, et al.
Urologia Internationalis|January 21, 2024
The Role of Multiparametric MRI (mpMRI) in the Prediction of Adverse Prostate Cancer Pathology in Radical Prostatectomy SpecimenAndreas Riedel, Marlene Michael, Jenny Grünberg, et al.
BJUI Compass|August 20, 2025
A machine learning algorithm for automatic tumour board recommendations in prostate cancer patientsMarcus Sondermann, Hannah Glaser, Anke Rentsch, et al.
World Journal of Urology|February 16, 2024
Old for young kidney transplantation: a responsible option for our patients to reduce waiting time?Philip Zeuschner, Janine Mihm, Urban Sester, et al.
Lancet (London, England)|January 24, 2021
Neuropathology associated with SARS-CoV-2 infectionKristof Egervari, Christian Thomas, Johannes A Lobrinus, et al.
Molecular Cancer Therapeutics|March 16, 2013
A novel antiandrogen, Compound 30, suppresses castration-resistant and MDV3100-resistant prostate cancer growth in vitro and in vivoHidetoshi Kuruma, Hiroaki Matsumoto, Masaki Shiota, et al.
Urologic Oncology|August 5, 2019
Comparative assessment of docetaxel for safety and efficacy between hormone-sensitive and castration-resistant metastatic prostate cancerRene Mager, Olga Savko, Katharina Böhm, et al.
World Journal of Urology|November 1, 2022
Negative multiparametric magnetic resonance imaging for prostate cancer: further outcome and consequencesMaximilian Haack, Vanessa Miksch, Zhe Tian, et al.
Open Forum Infectious Diseases|March 7, 2023
Hearing Loss in Bacterial Meningitis Revisited-Evolution and RecoveryElisa Skovgaard Jensen, Per Cayé-Thomasen, Jacob Bodilsen, et al.
Pageof 45